Ozanimod has an improved nonclinical safety profile relative to fingolimod

Meier-Davis, S; Brooks, J; Wilson, J; Dines, K; Martinborough, E

MULTIPLE SCLEROSIS JOURNAL, 2017; 23 ( ): 383

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索